113 related articles for article (PubMed ID: 2936060)
1. Tay-Sachs disease with conspicuous cranial computerized tomographic appearances.
Watanabe K; Mukawa A; Muto K; Nishikawa J; Takahashi S
Acta Pathol Jpn; 1985 Nov; 35(6):1521-32. PubMed ID: 2936060
[TBL] [Abstract][Full Text] [Related]
2. Naturally occurring GM2 gangliosidosis in two Muntjak deer with pathological and biochemical features of human classical Tay-Sachs disease (type B GM2 gangliosidosis).
Fox J; Li YT; Dawson G; Alleman A; Johnsrude J; Schumacher J; Homer B
Acta Neuropathol; 1999 Jan; 97(1):57-62. PubMed ID: 9930895
[TBL] [Abstract][Full Text] [Related]
3. GM2-gangliosidosis, AB variant: clinico-pathological study of a case.
de Baecque CM; Suzuki K; Rapin I; Johnson AB; Whethers DL
Acta Neuropathol; 1975 Dec; 33(3):207-26. PubMed ID: 174379
[TBL] [Abstract][Full Text] [Related]
4. Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease?
Rosengren B; Månsson JE; Svennerholm L
J Neurochem; 1987 Sep; 49(3):834-40. PubMed ID: 3612128
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
Poulos A; Holding J; Carey WF
Clin Chim Acta; 1982 Apr; 120(3):331-40. PubMed ID: 6210469
[TBL] [Abstract][Full Text] [Related]
6. Autophagic flux is impaired in the brain tissue of Tay-Sachs disease mouse model.
Sengul T; Can M; Ateş N; Seyrantepe V
PLoS One; 2023; 18(3):e0280650. PubMed ID: 36928510
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
[TBL] [Abstract][Full Text] [Related]
8. Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase A.
Hoffman LM; Brooks SE; Amsterdam D; Oropello J; Schneck L
J Neurosci Res; 1980; 5(5):413-7. PubMed ID: 7441795
[TBL] [Abstract][Full Text] [Related]
9. MR findings in Tay-Sachs disease.
Mugikura S; Takahashi S; Higano S; Kurihara N; Kon K; Sakamoto K
J Comput Assist Tomogr; 1996; 20(4):551-5. PubMed ID: 8708054
[TBL] [Abstract][Full Text] [Related]
10. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
Harzer K
Clin Chim Acta; 1983 Nov; 135(1):89-93. PubMed ID: 6228344
[No Abstract] [Full Text] [Related]
11. Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model.
Martino S; Cavalieri C; Emiliani C; Dolcetta D; Cusella De Angelis MG; Chigorno V; Severini GM; Sandhoff K; Bordignon C; Sonnino S; Orlacchio A
Neurochem Res; 2002 Aug; 27(7-8):793-800. PubMed ID: 12374215
[TBL] [Abstract][Full Text] [Related]
12. Retinal amacrine cell involvement in Tay-Sachs disease.
Nagashima K; Kikuchi F; Suzuki Y; Abe T
Acta Neuropathol; 1981; 53(4):333-6. PubMed ID: 7223376
[TBL] [Abstract][Full Text] [Related]
13. Two siblings, including a fetus, with Tay-Sachs disease.
Yamada E; Matsumoto M; Hazama F; Momoi T; Sudo M
Acta Pathol Jpn; 1981 Nov; 31(6):1053-61. PubMed ID: 7315310
[TBL] [Abstract][Full Text] [Related]
14. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of two variants of type-AB GM2-gangliosidosis using chromogenic substrates.
Li YT; Hirabayashi Y; Li SC
Am J Hum Genet; 1983 May; 35(3):520-2. PubMed ID: 6222647
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K
Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574
[TBL] [Abstract][Full Text] [Related]
17. Gangliosides in SV-40-transformed cells derived from Tay-Sachs disease fetal brain.
Hoffman LM; Brooks SE; Stein MR; Adachi M; Schneck L
Metab Brain Dis; 1989 Jun; 4(2):87-93. PubMed ID: 2547146
[TBL] [Abstract][Full Text] [Related]
18. GM2 ganglioside and pyramidal neuron dendritogenesis.
Walkley SU; Siegel DA; Dobrenis K
Neurochem Res; 1995 Nov; 20(11):1287-99. PubMed ID: 8786814
[TBL] [Abstract][Full Text] [Related]
19. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
Charrow J; Binns HJ
Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
[TBL] [Abstract][Full Text] [Related]
20. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
Hechtman P; Boulay B; Bayleran J; Andermann E
Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
